Medtronic (NYSE:MDT) reported new clinical data from its Navablate study of bronchoscopic microwave ablation with its Emprint ablation catheter kit to treat malignant lung nodules. “Patients with malignant lesions in the lung often have limited therapy options due to lesion locations, comorbidities and treatment side effects,” said one of the … [Read more...] about Medtronic releases Navablate study results for bronchoscopic microwave ablation
Researchers in Zurich reported today that they have invented a manufacturing technique to build "micromachines" out of metal and plastic in which these two materials are interlocked as closely as links in a chain. These robots are so tiny that they can maneuver through blood vessels and deliver medications to certain points in the body — a goal … [Read more...] about Swiss scientists make ‘micromachines’ for self-deploying stents and more
Royal Philips (NYSE:PHG) announced today that one-year results of its Define PCI study that reported improved outcomes and less recurrent angina. The Define PCI study assessed the level of residual ischemia found in patients following a percutaneous coronary intervention (PCI) using a blinded instant wave-free ratio (iFR) pullback measurement, … [Read more...] about Philips touts post-stent imaging study results
A pair of studies of Abbott’s Xience drug-eluting stent showed no difference between shorter courses of treatment with dual antiplatelet therapy (DAPT) compared with 12 months of DAPT following implantation of the XIENCE drug-eluting stent (DES) in patients who are at a high risk of bleeding. Abbott presented the late-breaking data today at TCT … [Read more...] about Abbott touts Xience DES study results
Medtronic (NYSE:MDT) recently announced the results of a study showing that some kidney disease patients who had a drug-coated balloon (DCB) implanted to treat arteriovenous (AV) failure experienced fewer interruptions of dialysis treatment. Many end-stage renal disease (ESRD) patients require AV fistulae in order to receive continuous dialysis. … [Read more...] about Study: Medtronic’s drug-coated balloon reduces dialysis interruptions
The COVID-19 pandemic is expected to grow the medical tubing industry by a little more than 13% by 2021, according to an analysis by Markets and Markets. The U.S. medical tubing market is expected to be worth $2.9 billion in 2021, up from this year's value of $2.6 billion. With a consumer annual growth rate of 13.2%, the market growth can be … [Read more...] about COVID-19 to grow medical tubing market 13% by 2021
Amid the global crisis caused by the coronavirus pandemic, hospitals and healthcare facilities are reporting shortages of vital equipment that not only keeps the patients safe, but the staffers, too. One important device for which demand has ramped up is ventilators for patients who need assistance with their breathing due to the respiratory … [Read more...] about Could these DIY ventilators stop coronavirus from killing people?
The medical tubing market is expected to be worth $11.9 billion by 2025, according to an analysis from Grand View Research. Grand View Research suggests the industry will expand at a revenue-based consumer annual growth rate of 9.2% over the next five years. Increased health expenditures from individuals and increased emphasis on healthcare by … [Read more...] about Medical tubing market to be worth $12 billion in 2025
A new way to replace a patient's damaged blood vessels may be on its way, as researchers in France are figuring out a way to "knit" new vessels with a collagen-based extracellular matrix. Inserm researcher Nicolas L'Heureux and his colleagues at Inserm/Université de Bordeaux's tissue bioengineering unit published a study in Acta Biomaterialia to … [Read more...] about Is it possible to ‘knit’ replacement blood vessels?
Bluegrass Vascular Technologies recently announced positive results from a clinical study of its Surfacer Inside-Out catheter system. The San Antonio-based company said the trial represents the first independent, multicenter study investigating the applicability of the Surfacer system, which is designed to provide access to the jugular vein to … [Read more...] about Bluegrass Vascular touts results of Surfacer catheter trial